GovChime
Notice ID: e7b1cc12d9d644c291c9f2c1fbb194f2Special Notice

DOD USAMRDC FY23-FY27 BROAD AGENCY ANNOUNCEMENT for Extramural Medical Research Department of Defense Dept. of the Army -- USAMRAA

Active, responses due . Full description on SAM.gov.

Overview

Response deadline
11:59 PM EDT
Posted
November 8, 2023
Notice type
Special Notice
Agency
Department of WarDEFENSE HEALTH AGENCY (DHA)

Notice details

Office
ARMY MED RES ACQ ACTIVITY
Last updated
Oct 28, 2026
First published
Last updated on SAM.gov

Identifiers

Solicitation number
HT9425-23-S-BAA1
Notice ID
e7b1cc12d9d644c291c9f2c1fbb194f2

Description

The USAMRDC’s mission is to provide solutions to medical problems of importance to the American Service Member at home and abroad, as well as to the general public at large. The scope of this effort and the priorities attached to specific projects are influenced by changes in military and civilian medical science and technology (S&T), operational requirements, military threat assessments, and national defense strategies. Extramural research and development programs play a vital role in the fulfillment of the objectives established by the USAMRDC. General information on the USAMRDC can be obtained at https://mrdc.health.mil/. This BAA is intended to solicit extramural research and development ideas using the authority provided by 10 USC 4001. The BAA is issued under the provisions of the Competition in Contracting Act of 1984 (Public Law 98-369), as implemented in FAR 6.102(d)(2) and 35.016 and in Department of Defense Grant and Agreement Regulations (DoDGARs) 22.315. In accordance with FAR 35.016, projects funded under this BAA must be for basic and applied research to support scientific study and experimentation directed toward advancing the state-of-the-art or increasing knowledge or understanding rather than focusing on development of a specific system or hardware solution. Research and development funded through this BAA are intended and expected to benefit and inform both military and civilian medical practice and knowledge. This BAA utilizes competitive procedures in accordance with 10 USC 2302(2)(B) for the selection for award of S&T proposals/applications. For the purposes of this BAA, S&T includes activities involving basic research, applied research, advanced technology development, and, under certain conditions, may include activities involving advanced component development and prototypes. The selection process is highly competitive, and the quantity of meaningful submissions (both pre-proposals/pre-applications and full proposals/applications) received typically exceeds the number of awards that available funding can support. This BAA provides a general description of USAMRDC’s research and development programs, including Research Areas of Interest, evaluation and selection criteria, pre-proposal/ pre-application and full proposal/application preparation instructions, and general administrative information. Specific submission information and additional administrative requirements can be found in the document titled, “General Submission Instructions,” which is available on Grants.gov along with this BAA. The FY23-FY27 USAMRDC BAA is continuously open for a 5-year period, from October 1, 2022 through September 30, 2027, at 11:59 p.m. Eastern Time. Submission of a pre-proposal/pre-application is required and must be submitted through the electronic Biomedical Research Application Portal (eBRAP) (https://eBRAP.org/). Pre-proposals/pre-applications may be submitted at any time throughout the 5-year period. If the USAMRDC is interested in receiving a full proposal/application, the Principal Investigator will be sent an invitation to submit via eBRAP. A full proposal/application must be submitted through Grants.gov (http://www.grants.gov/). Invited full proposals/applications can be submitted under this FY23-FY27 BAA through September 30, 2027.

Full description on SAM.gov

Award Overview

No prior contract identified

No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.

Contacts

Documents

Files (1)

  • Synopsis HT9425-23-S-BAA1.pdf

    149 KBAdded in Special Notice version 1Posted
    Download

Lifecycle

  1. 1
    Version 1Special Notice

    DOD USAMRDC FY23-FY27 BROAD AGENCY ANNOUNCEMENT for ExtramuralMedical Research Department of Defense Dept. of the Army -- USAMRAA

    Notice fbbe7cc8fc9a4b8ba825b0954c85f709 on SAM.gov

  2. 2
    Version 2Special Notice

    DOD USAMRDC FY23-FY27 BROAD AGENCY ANNOUNCEMENT for Extramural Medical Research Department of Defense Dept. of the Army -- USAMRAA

    Notice 617370e11e4c48bbab3cd21bc5aee19e on SAM.gov

  3. 3
    Version 3Special Notice

    DOD USAMRDC FY23-FY27 BROAD AGENCY ANNOUNCEMENT for Extramural Medical Research Department of Defense Dept. of the Army -- USAMRAA

    Notice d73759f632ac4412abfddadc4990bf7e on SAM.gov

  4. 4
    Version 4Special NoticeCurrent

    DOD USAMRDC FY23-FY27 BROAD AGENCY ANNOUNCEMENT for Extramural Medical Research Department of Defense Dept. of the Army -- USAMRAA

    Notice e7b1cc12d9d644c291c9f2c1fbb194f2 on SAM.gov

  5. 7
    Version 7Award NoticeArchived

    Type changed from Special Notice to Award Notice

    DOD USAMRDC FY23-FY27 BROAD AGENCY ANNOUNCEMENT for Extramural Medical Research Department of Defense Award for Multiplexed Assay for Immune Responses to Infectious Diseases

    Notice 4da194e6aaf743a8a2ca1edcd7bdae2d on SAM.gov

Similar Opportunities

No similar opportunities found

No similar opportunities match this opportunity's profile.

Additional Details

Solicitation Number

HT9425-23-S-BAA1

Archive Date

Oct 15, 2027

Office Address

FORT DETRICK, MD, 21702